Programme
Download as PDF
Conference room
09:05 - 09:15
Case report of a patient receiving tebentafusp (2+ line) over 52 weeks
09:15 - 09:30
Q&A session
09:30 - 09:40
Heterogeneous UM cells with BRAF mutations — long time survival on tebentafusp
09:40 - 09:55
Q&A session
09:55 – 10:05
Break
10 min
10:05 - 10:15
Case report of a patient with 4th line tebentafusp treatment
10:15 - 10:30
Q&A session
10:30 - 10:40
Case report of a pregnant patient diagnosed with mUM
10:40 - 10:55
Q&A session